01/21/2025
5:04 AM | Poseida Therapeutics (Filer)
| Form 15-12G | |
01/15/2025
3:27 PM | Malin Life Sciences Holdings Ltd (Filed by)
Poseida Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
01/13/2025
3:05 PM | Pentwater Capital Management LP (Filed by)
Poseida Therapeutics (Subject)
| Form SCHEDULE 13D/A | |
01/12/2025
11:15 PM | Poseida Therapeutics (Filer)
| Form EFFECT | |
01/12/2025
11:15 PM | Poseida Therapeutics (Filer)
| Form EFFECT | |
01/08/2025
3:17 PM | Poseida Therapeutics (Filer)
| Form S-8 POS | |
01/08/2025
3:19 PM | Poseida Therapeutics (Filer)
| Form S-8 POS | |
01/08/2025
3:01 PM | Poseida Therapeutics (Filer)
| Form POS AM | |
01/08/2025
3:04 PM | Poseida Therapeutics (Filer)
| Form POS AM | |
01/08/2025
3:11 PM | Poseida Therapeutics (Filer)
| Form S-8 POS | |
01/08/2025
3:13 PM | Poseida Therapeutics (Filer)
| Form S-8 POS | |
Get the Latest News and Ratings for PSTX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Poseida Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
01/08/2025
3:15 PM | Poseida Therapeutics (Filer)
| Form S-8 POS | |
01/08/2025
1:07 PM | Poseida Therapeutics (Issuer)
Yarema Kristin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2025
1:08 PM | Gergen Mark J (Reporting)
Poseida Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2025
1:09 PM | LEONHARDT HARRY J (Reporting)
Poseida Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2025
1:10 PM | Poseida Therapeutics (Issuer)
Rizvi Syed Ali-aamir (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2025
1:11 PM | Mylet Johanna (Reporting)
Poseida Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2025
1:12 PM | BAUM CHARLES M (Reporting)
Poseida Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2025
1:14 PM | Collins Cynthia (Reporting)
Poseida Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2025
1:15 PM | Lloyd Marcea Bland (Reporting)
Poseida Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2025
1:16 PM | Poseida Therapeutics (Issuer)
Schmid John P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2025
1:17 PM | Corning Luke (Reporting)
Poseida Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2025
1:17 PM | Amado Rafael (Reporting)
Poseida Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2025
8:06 AM | Nasdaq Stock Market LLC (Filed by)
Poseida Therapeutics (Subject)
| Form 25-NSE | |
01/08/2025
7:47 AM | Poseida Therapeutics (Subject)
| Form SC 14D9/A | |
01/08/2025
7:55 AM | Poseida Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/08/2025
7:37 AM | Poseida Therapeutics (Subject)
ROCHE HOLDINGS INC (Filed by)
| Form SC TO-T/A | |
01/07/2025
7:01 AM | Poseida Therapeutics (Subject)
ROCHE HOLDINGS INC (Filed by)
| Form SC TO-T/A | |
01/07/2025
7:06 AM | Poseida Therapeutics (Subject)
| Form SC 14D9/A | |
01/06/2025
4:28 PM | Poseida Therapeutics (Subject)
| Form SC 14D9/A | |
01/06/2025
2:45 PM | Poseida Therapeutics (Subject)
ROCHE HOLDINGS INC (Filed by)
| Form SC TO-T/A | |
01/03/2025
7:24 PM | Gergen Mark J (Reporting)
Poseida Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/27/2024
6:08 PM | Poseida Therapeutics (Subject)
| Form SC 14D9/A | |
12/27/2024
4:28 PM | Poseida Therapeutics (Subject)
ROCHE HOLDINGS INC (Filed by)
| Form SC TO-T/A | |
12/11/2024
4:17 PM | Gergen Mark J (Reporting)
Poseida Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/09/2024
4:26 PM | Poseida Therapeutics (Subject)
| Form SC 14D9 | |
11/27/2024
6:39 PM | Gergen Mark J (Reporting)
Poseida Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/27/2024
6:01 PM | Pentwater Capital Management LP (Filed by)
Poseida Therapeutics (Subject)
| Form SC 13D/A | |
11/27/2024
6:18 AM | Poseida Therapeutics (Subject)
| Form SC14D9C | |
11/26/2024
3:22 PM | Gergen Mark J (Reporting)
Poseida Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/26/2024
3:05 PM | Poseida Therapeutics (Subject)
ROCHE HOLDINGS INC (Filed by)
| Form SC TO-C | |
Your trading day could end at 11 AM (Ad) What do you usually do between 9:35 AM and 11:00 AM?
Catch up on emails? Attend a meeting? Maybe grab a coffee?
For me, it's become the most important part of my trading day.
85 minutes. That's usually all it takes.
Set up at 9:35 AM… Check back at 11:00 AM.
And when things work out, there's an extra $100 to $150 in my account… on a $1000 starting stake.
Sounds too simple, doesn't it? Tap this link and see the complete breakdown. |
11/26/2024
5:53 AM | Poseida Therapeutics (Subject)
| Form SC14D9C | |
11/26/2024
6:00 AM | Poseida Therapeutics (Subject)
ROCHE HOLDINGS INC (Filed by)
| Form SC TO-C | |
11/26/2024
5:49 AM | Poseida Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
8:15 AM | Poseida Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/30/2024
7:00 AM | Poseida Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/14/2024
11:15 PM | Poseida Therapeutics (Filer)
| Form EFFECT | |
06/07/2024
12:30 PM | BlackRock Inc. (Filed by)
Poseida Therapeutics (Subject)
| Form SC 13G/A | |
05/14/2024
3:06 PM | Poseida Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/05/2024
11:15 PM | Poseida Therapeutics (Filer)
| Form EFFECT | |
05/01/2024
8:07 AM | Poseida Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/17/2024
8:17 AM | Poseida Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/08/2024
4:01 PM | Poseida Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
04/08/2024
3:30 PM | Poseida Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/04/2024
4:29 PM | Mylet Johanna (Reporting)
Poseida Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/09/2024
8:28 AM | FMR LLC (Filed by)
Poseida Therapeutics (Subject)
| Form SC 13G/A | |
02/08/2024
3:10 PM | Poseida Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
Free PSTX Stock Alerts